IDEXX Laboratories Inc at Stifel Jaws & Paws Conference (Virtual) Transcript
All right. Perfect. Great. Thanks. Good afternoon. Jon Block with Stifel. And we're transitioning to animal health in IDEXX. Thanks guys for joining us. We have with us Jay Mazelsky, President and CEO; and Brian McKeon, Executive Vice President and Chief Financial Officer.
Same sort of approach. I've been saying I've got a bunch of questions. Guys, if you have questions, please raise your hand or just shout out, and we'll get after them.
Questions & Answers
I'm going to start with trends. And so we get a decent look on U.S. Vet volumes from other sources throughout the quarter, which seems highly correlated to your visits. And overall, U.S. clinical visits for IDEXX in 1Q '23 was basically flat. I think Brian you mentioned it, it weakened a bit exiting the quarter. But you talked about
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
